Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT04769817
Overview
This is a descriptive, observational, prospective, open-ended, registry utilising electronic data capture to collect information on the outcomes of men treated with prostate specific-membrane antigen (PSMA) theranostics.
Sponsor
Peter MacCallum Cancer Centre
Phase
N/A
Contacts
Elizabeth Medhurst
prostic@petermac.org
+61 3 8559 8617
Gaurav Sharma
gaurav.sharma@petermac.org
03 85596830
ClinicalTrials.gov
NCT04769817Help us improve your experience